116 related articles for article (PubMed ID: 14505127)
1. Low-dose azathioprine is effective and safe for maintenance of remission in patients with ulcerative colitis.
Hibi T; Naganuma M; Kitahora T; Kinjyo F; Shimoyama T
J Gastroenterol; 2003; 38(8):740-6. PubMed ID: 14505127
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenetics during standardised initiation of thiopurine treatment in inflammatory bowel disease.
Hindorf U; Lindqvist M; Peterson C; Söderkvist P; Ström M; Hjortswang H; Pousette A; Almer S
Gut; 2006 Oct; 55(10):1423-31. PubMed ID: 16543290
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of optimised thiopurine therapy in patients with moderate-to-severe ulcerative colitis: retrospective long-term follow-up from two randomised trials.
Mertz Nielsen A; Theede K; Gluud LL; Kiszka-Kanowitz M
Scand J Gastroenterol; 2024 Jun; 59(6):669-673. PubMed ID: 38444060
[TBL] [Abstract][Full Text] [Related]
4. Treatment efficacy and safety of low-dose azathioprine in chronic active ulcerative colitis patients: A meta-analysis and systemic review.
Luan ZJ; Li Y; Zhao XY; Wang L; Sun YH; Wang SY; Qian JM
J Dig Dis; 2016 Oct; 17(10):652-659. PubMed ID: 27450969
[TBL] [Abstract][Full Text] [Related]
5. Two brothers with skewed thiopurine metabolism in ulcerative colitis treated successfully with allopurinol and mercaptopurine dose reduction.
Hoentjen F; Hanauer SB; de Boer NK; Rubin DT
Dig Dis Sci; 2012 Jan; 57(1):250-3. PubMed ID: 22147254
[TBL] [Abstract][Full Text] [Related]
6. Azathioprine-induced Acute Pancreatitis in Patients with Inflammatory Bowel Diseases--A Prospective Study on Incidence and Severity.
Teich N; Mohl W; Bokemeyer B; Bündgens B; Büning J; Miehlke S; Hüppe D; Maaser C; Klugmann T; Kruis W; Siegmund B; Helwig U; Weismüller J; Drabik A; Stallmach A;
J Crohns Colitis; 2016 Jan; 10(1):61-8. PubMed ID: 26468141
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of Switching to Adalimumab for Maintenance of Remission Following Induction Therapy with Tacrolimus in Patients with Ulcerative Colitis.
Numa K; Kakimoto K; Tanaka Y; Mizuta N; Kinoshita N; Nakazawa K; Koshiba R; Hirata Y; Ota K; Miyazaki T; Nakamura S; Higuchi K; Nishikawa H
J Clin Med; 2023 Oct; 12(20):. PubMed ID: 37892837
[TBL] [Abstract][Full Text] [Related]
8. Patterns of 6-mercaptopurine and azathioprine maintenance therapy among a cohort of commercially insured individuals diagnosed with Crohn's disease in the United States.
Lund JL; Cook SF; Allen JK; Carroll CF; Kappelman MD
Clin Epidemiol; 2013; 5():501-12. PubMed ID: 24348071
[TBL] [Abstract][Full Text] [Related]
9. The haemotoxicity of azathioprine in repeat dose studies in the female CD-1 mouse.
Molyneux G; Gibson FM; Chen CM; Marway HK; McKeag S; Mifsud CV; Pilling AM; Whayman MJ; Turton JA
Int J Exp Pathol; 2008 Apr; 89(2):138-58. PubMed ID: 18336531
[TBL] [Abstract][Full Text] [Related]
10. Optimising use of thiopurines in inflammatory bowel disease.
Raj LS; Hawthorne AB
Frontline Gastroenterol; 2010 Apr; 1(1):44-51. PubMed ID: 28839543
[TBL] [Abstract][Full Text] [Related]
11. Association of ITPA 94C>A genetic polymorphisms with azathioprine induced adverse effects in the South Indian population.
Deva R; Rajendran P; Ramasamy S; Selvan S; Ramasamy K
Drug Metab Pers Ther; 2024 Mar; 39(1):21-26. PubMed ID: 38097396
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenetic Effect of Thiopurine Methyl Transferase (TPMT) Gene Expression and Serum TNF on the Imuran Response in Ulcerative Colitis (UC) Iraqi Patients.
Ali N; Abdulkareem R
Rep Biochem Mol Biol; 2023 Oct; 12(3):438-447. PubMed ID: 38618257
[TBL] [Abstract][Full Text] [Related]
13. A Case Report of Follicular Lymphoma in a Crohn's Disease Patient Treated With Azathioprine.
Kottavadakkeel N; Farzina R; Rajaram A; Mannath S; Sunil A
Cureus; 2023 Dec; 15(12):e50839. PubMed ID: 38125685
[TBL] [Abstract][Full Text] [Related]
14. Azathioprine dose escalation in inflammatory bowel disease.
Rayner CK; Hart AL; Hayward CM; Emmanuel AV; Kamm MA
Aliment Pharmacol Ther; 2004 Jul; 20(1):65-71. PubMed ID: 15225172
[TBL] [Abstract][Full Text] [Related]
15. The efficacy of low dose azathioprine/6-mercaptopurine in patients with inflammatory bowel disease.
Kim DU; Kim YH; Kim BJ; Chang DK; Son HJ; Rhee PL; Kim JJ; Rhee JC
Hepatogastroenterology; 2009; 56(94-95):1395-402. PubMed ID: 19950798
[TBL] [Abstract][Full Text] [Related]
16. Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis.
Timmer A; Patton PH; Chande N; McDonald JW; MacDonald JK
Cochrane Database Syst Rev; 2016 May; 2016(5):CD000478. PubMed ID: 27192092
[TBL] [Abstract][Full Text] [Related]
17. Long-term efficacy and safety of azathioprine in ulcerative colitis.
Sood R; Ansari S; Clark T; Hamlin PJ; Ford AC
J Crohns Colitis; 2015 Feb; 9(2):191-7. PubMed ID: 25518053
[TBL] [Abstract][Full Text] [Related]
18. Imuran in the treatment of ulcerative colitis.
Theodor E; Niv Y; Bat L
Am J Gastroenterol; 1981 Sep; 76(3):262-6. PubMed ID: 7315823
[TBL] [Abstract][Full Text] [Related]
19. Standard-dose versus low-dose azathioprine in the treatment of Crohn's disease: A prospective randomized study.
Zhang Y; Xia JJ; Xiao P; Zhao Y; Ye LN; Li XL; Lin ZW; Xu ZJ; Huang YB; Wang MY; Qian JM; Hu PJ; Cao Q
J Dig Dis; 2016 Nov; 17(11):747-755. PubMed ID: 27653444
[TBL] [Abstract][Full Text] [Related]
20. TPMT testing before azathioprine therapy?
Drug Ther Bull; 2009 Jan; 47(1):9-12. PubMed ID: 19129430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
